Abstract
Introduction: Rhinoviruses (RVs) are well-known trigger of wheezing episodes in children with asthma. Their role in other pediatric chronic medical conditions is not fully know. Methods: Patients ≤21 years hospitalized or evaluated as outpatients with symptomatic RV infection were identified from 2011-2013. Patients were categorized based on the type of underlying disease and differences in clinical parameters, RV loads (CT values), viral and bacterial coinfections and clinical outcomes compared between groups. Multivariable analyses were performed to identify the comorbidities associated with oxygen requirement, PICU admission, and prolonged hospitalization. Results: Of 1,899 children analyzed, 77.7% (n=1477) had an underlying comorbidity including asthma (36.8%), prematurity (7.7%), chronic respiratory diseases (6.4%), congenital heart disease (CHD, 3.2%), immunocompromised hosts (ICH; 1.4%) and others (22.2%). Prevalence of comorbidities increased with age (70%, infants vs 84%-87%, children >1 year; p<0.0001). Median RV loads were intermediate-high (24-26 CT values), irrespective of the underlying disease. RV/ viral co-detections were identified in 11% of ICH vs 20%- 30% in all other children while bacterial co-infections were identified in 2.9% of children. Multivariable models identified asthma, prematurity, CHD and bacterial coinfections consistently associated with all three clinical outcomes (p<0.0001). Older age and higher RV loads were also associated with increased odds of PICU admission. Conclusions: The prevalence of comorbidities was high in children with RV infections. Of those, asthma, prematurity and CHD were consistently associated with severe disease. Bacterial co-infections and higher RV loads further predicted worse clinical outcomes, highlighting the importance of identifying clinical phenotypes for future targeted interventions.
Competing Interest Statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: AM has received fees for participation in Advisory Boards from Janssen, Merck, Pfizer, Moderna, Enanta, AstraZeneca and Sanofi-Pasteur and grants from NIH, Merck and Janssen to institution. OR has received fees for participation in Advisory Boards from Merck, Pfizer, AstraZeneca and Sanofi-Pasteur and grants from NIH, Bill & Melinda Gates Foundation, Merck and Janssen to institution. ALL has received research grants from BioFire, Cepheid, Luminex, and Diasorin, and consulting fees from Medscape, Biorad and BioFire. The remaining authors have no conflicts of interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by Nationwide Children’s Hospital (NCH) Institutional Review Board (IRB ID-STUDY00001015).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files and summarized for publication purposes
